Sintx Stock (NASDAQ:SINT)


RevenueOwnershipFinancialsChart

Previous Close

$1.90

52W Range

$1.81 - $45.60

50D Avg

$3.14

200D Avg

$3.61

Market Cap

$4.65M

Avg Vol (3M)

$1.34M

Beta

1.12

Div Yield

-

SINT Company Profile


Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

20

IPO Date

Feb 13, 2014

Website

SINT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 24
Grant and Contract$1.64M
Product$1.25M

Fiscal year ends in Dec 24 | Currency in USD

SINT Financial Summary


Dec 24Dec 23Dec 22
Revenue$2.89M$2.63M$601.00K
Operating Income$-14.05M$-13.36M$-11.34M
Net Income$-11.02M$-8.26M$-16.49M
EBITDA$-14.05M$-6.60M$-11.06M
Basic EPS$-1.49$-35.43$-54.67
Diluted EPS$-1.48$-624.48$-51.96

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q3 17Nov 21, 17 | 11:00 AM
Q3 16Nov 10, 16 | 5:00 PM
Q2 16Aug 11, 16 | 5:00 PM

Peer Comparison


TickerCompany
IRIXIRIDEX Corporation
NAOVNanoVibronix, Inc.
RSLSReShape Lifesciences Inc.
HSDTHelius Medical Technologies, Inc.
BBLGBone Biologics Corporation
NUWENuwellis, Inc.
TIVCTivic Health Systems, Inc.
BJDXBluejay Diagnostics, Inc.
NXLNexalin Technology, Inc.